LHON
MCID: LBR030
MIFTS: 53

Leber Optic Atrophy (LHON) malady

Categories: Genetic diseases, Rare diseases, Eye diseases, Metabolic diseases, Neuronal diseases

Aliases & Classifications for Leber Optic Atrophy

About this section

Aliases & Descriptions for Leber Optic Atrophy:

Name: Leber Optic Atrophy 52 48 25 54 70 35
Leber Hereditary Optic Neuropathy 11 23 48 24 25 54 52 70 13
Lhon 23 48 24 25 54 70
Leber's Optic Atrophy 11 23 24 25
Leber's Optic Neuropathy 23 24 25
Leber's Hereditary Optic Neuropathy 11 25
Hereditary Optic Neuroretinopathy 24 25
Optic Atrophy, Hereditary, Leber 39 68
Optic Atrophy Leber Type 70 27
Leber's Disease 23 24
 
Leber Optic Atrophy, Susceptibility to 12
Lebers Hereditary Optic Neuropathy 50
Leber Hereditary Optic Atrophy 25
Leber Congenital Amaurosis 68
Optic Atrophy, Leber Type 48
Leber Plus Disease 54
Lhon Plus Disease 54
Leber’s Disease 48
Loa 70

Characteristics:

Orphanet epidemiological data:

54
leber hereditary optic neuropathy:
Inheritance: Mitochondrial inheritance; Prevalence: 1-9/100000 (Worldwide); Age of onset: Adolescent,Adult; Age of death: normal life expectancy
leber plus disease:
Inheritance: Mitochondrial inheritance; Prevalence: <1/1000000 (Europe); Age of onset: Adolescent,Adult,Childhood,Infancy; Age of death: normal life expectancy

HPO:

64
leber optic atrophy:
Inheritance: x-linked inheritance
leber hereditary optic neuropathy:
Inheritance: heterogeneous, mitochondrial inheritance
Onset and clinical course: incomplete penetrance

GeneReviews:

23
Penetrance: lhon-causing mtdna pathogenic variants are characterized by reduced penetrance. an individual can only develop lhon if a pathogenic mtdna lhon-causing variant is present, but approximately 50% of males and 90% of females who harbor a primary lhon-causing mtdna pathogenic variant do not develop blindness. it must be stressed that penetrance can vary markedly in different branches of the same family and between families harboring the same lhon-causing mtdna pathogenic variants, which complicates genetic counseling at the individual level. additional environmental and genetic factors interact with the primary mtdna pathogenic variant and determine whether an individual ultimately develops optic nerve dysfunction and visual failure. the two most important risk factors for visual loss are sex and age (see table 4) [yu-wai-man et al 2009]...


Classifications:



External Ids:

Disease Ontology11 DOID:705
ICD1030 H47.22
MeSH39 D029242
NCIt45 C84808
ICD10 via Orphanet31 H47.2
MedGen37 C0917796

Summaries for Leber Optic Atrophy

About this section
OMIM:52 LHON presents in midlife as acute or subacute central vision loss leading to central scotoma and blindness. The disease... (535000) more...

MalaCards based summary: Leber Optic Atrophy, also known as leber hereditary optic neuropathy, is related to loiasis and leber hereditary optic neuropathy with dystonia, and has symptoms including ataxia, ataxia and static tremor. An important gene associated with Leber Optic Atrophy is MT-ND6 (Mitochondrially Encoded NADH:Ubiquinone Oxidoreductase Core Subunit 6), and among its related pathways are Cardiac muscle contraction and GABAergic synapse. Affiliated tissues include eye.

Genetics Home Reference:25 Leber hereditary optic neuropathy (LHON) is an inherited form of vision loss. Although this condition usually begins in a person's teens or twenties, rare cases may appear in early childhood or later in adulthood. For unknown reasons, males are affected much more often than females.

NIH Rare Diseases:48 Leber hereditary optic neuropathy (lhon) is a condition characterized by vision loss. vision loss is typically the only symptom of lhon. some families with additional signs and symptoms have been reported and are said to have "lhon plus", a condition which includes vision loss, tremors, and abnormalities of the electrical signals that control the heartbeat (cardiac conduction defects). some affected individuals develop features similar to multiple sclerosis. lhon is caused by mutations in the mt-nd1, mt-nd4, mt-nd4l, and mt-nd6 genes. lhon has a mitochondrial pattern of inheritance; however, there are many cases in which there are no other cases of lhon in the family. treatment is supportive and may include visual aids. there is ongoing research for more effective treatment.  last updated: 3/13/2017

UniProtKB/Swiss-Prot:70 Leber hereditary optic neuropathy: A maternally inherited disease resulting in acute or subacute loss of central vision, due to optic nerve dysfunction. Cardiac conduction defects and neurological defects have also been described in some patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.

Description from OMIM:52 308905

GeneReviews for NBK1174

Related Diseases for Leber Optic Atrophy

About this section

Diseases related to Leber Optic Atrophy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 53)
idRelated DiseaseScoreTop Affiliating Genes
1loiasis12.0
2leber hereditary optic neuropathy with dystonia11.3
3mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes11.0
4leber congenital amaurosis11.0
5hyperthyroxinemia, familial dysalbuminemic10.4MT-CO1, MT-CO3
6parkinson disease 6, early onset10.3MT-ND5, MT-ND6
7angiostrongyliasis10.3MT-CO1, MT-ND1
8abdominal tuberculosis10.3MT-CO1, MT-CYB, MT-ND1
9intracranial abscess10.3MT-CO1, MT-CYB, MT-ND3
10reproductive system disease10.3MT-ATP6, MT-CO1, MT-ND1
11ciliary dyskinesia, primary, 1710.3MT-CO1, MT-CYB
12brachymorphism-onychodysplasia-dysphalangism syndrome10.3OPA1, OPA3
13adenylosuccinase deficiency10.3MT-CO1, MT-ND4
14cylindrical spirals myopathy10.3MT-ATP6, MT-TK
15penis sarcoma10.3MT-CO3, MT-ND1
16syphilitic encephalitis10.3MT-CO1, MT-ND3, MT-ND5
17lentigo maligna melanoma10.3MT-ND1, MT-ND3, MT-ND4, MT-ND6
18multiple epiphyseal dysplasia with robin phenotype10.3MT-ND4, MT-ND5, MT-TK
19lrp5-related familial exudative vitreoretinopathy, autosomal dominant10.3MT-CO3, NDUFS4, OPA3
20filariasis10.3
21onchocerciasis10.3
22growth hormone deficiency, isolated partial10.3MT-ND4, MT-TK, OPA3
23oculoauricular syndrome10.3MT-CO1, MT-CYB
24enteropathica10.3MT-CO3, MT-ND1, MT-ND4, MT-ND5, MT-ND6
25mitochondrial dna depletion syndrome 14, cardioencephalomyopathic type10.3MT-ND1, MT-ND2
26ulcerative blepharitis10.3MT-ND4, NDUFA1
27carotid body cancer10.2MT-ATP6, MT-ND1, MT-ND4, MT-ND5, MT-ND6
28status asthmaticus10.2MT-ND4, OPA1
29spinocerebellar ataxia, autosomal recessive 1510.2MT-ND4, MT-ND6, OPA1, OPA3, OPN4
30mental retardation with spastic paraplegia10.2MT-ATP6, MT-CYB, MT-ND4, MT-ND5, MT-ND6, MT-TK
31nerve fibre bundle defect10.2MT-ND1, MT-ND4, MT-ND5, MT-ND6, MT-TK, OPA3
32retromolar area cancer10.1MT-CO3, MT-CYB, MT-ND1, MT-ND4, MT-ND5, MT-ND6
33mast cell neoplasm10.1MT-ATP6, MT-CO3, MT-ND1, MT-ND4, MT-ND5, MT-ND6
34mechanical strabismus10.1MYOC, OPN4
35myoclonic epilepsy associated with ragged-red fibers10.1MT-ATP6, MT-CO1, MT-CO3, MT-ND1, MT-ND4, MT-ND5
36allergic contact dermatitis of eyelid10.0MT-ND1, MT-ND4, MT-ND5, MT-ND6, MYOC, NDUFA1
37mucinous intrahepatic cholangiocarcinoma10.0MT-ATP6, MT-ND3, MT-ND4, MT-ND5, MT-ND6, MT-TK
38ndp-related retinopathies10.0MT-ATP6, MT-CO3, MT-ND1, MT-ND2, MT-ND3, MT-ND4
39autoimmune interstitial lung, joint, and kidney disease10.0MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5
40encephalopathy10.0
41meningoencephalitis9.8
42heart disease9.8
43endomyocardial fibrosis9.8
44angioedema9.8
45neuronitis9.8
46bjornstad syndrome9.8MT-ATP6, MT-CO1, MT-CO3, MT-ND1, MT-ND2, MT-ND3
47charcot-marie-tooth disease9.8
48tooth disease9.8
49nkx2-1-related disorders9.8MT-ATP6, MT-CO1, MT-CO3, MT-ND1, MT-ND3, MT-ND4
50spastic paraparesis9.8

Graphical network of the top 20 diseases related to Leber Optic Atrophy:



Diseases related to leber optic atrophy

Symptoms & Phenotypes for Leber Optic Atrophy

About this section

Symptoms by clinical synopsis from OMIM:

308905

Clinical features from OMIM:

308905,535000

Human phenotypes related to Leber Optic Atrophy:

 54 64 (show all 20)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 retinal telangiectasia64 54 Frequent (79-30%) HP:0007763
2 blurred vision64 54 Frequent (79-30%) HP:0000622
3 optic atrophy64 54 Frequent (79-30%) HP:0000648
4 slow decrease in visual acuity64 54 Very frequent (99-80%) HP:0007924
5 mitochondrial respiratory chain defects64 54 Very frequent (99-80%) HP:0200125
6 centrocecal scotoma64 54 Frequent (79-30%) HP:0000576
7 central scotoma64 54 Frequent (79-30%) HP:0000603
8 retinal vascular tortuosity64 54 Frequent (79-30%) HP:0012841
9 ataxia64 54 Occasional (29-5%) HP:0001251
10 postural tremor64 54 Occasional (29-5%) HP:0002174
11 myopathy64 54 Occasional (29-5%) HP:0003198
12 ventricular preexcitation64 54 Occasional (29-5%) HP:0004309
13 peripheral neuropathy64 54 Occasional (29-5%) HP:0009830
14 arrhythmia64 54 Occasional (29-5%) HP:0011675
15 leber optic atrophy64 HP:0001112
16 visual loss64 HP:0000572
17 optic neuropathy64 HP:0001138
18 polyneuropathy64 HP:0001271
19 dystonia64 HP:0001332
20 central retinal vessel vascular tortuosity64 HP:0007768

UMLS symptoms related to Leber Optic Atrophy:


ataxia, static tremor

Drugs & Therapeutics for Leber Optic Atrophy

About this section

Drugs for Leber Optic Atrophy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 37)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Idebenoneapproved, investigationalPhase 4, Phase 3, Phase 22158186-27-9
2AntioxidantsPhase 4, Phase 3, Phase 23050
3Protective AgentsPhase 4, Phase 3, Phase 27443
4Antirheumatic AgentsPhase 3, Phase 210956
5Peripheral Nervous System AgentsPhase 323689
6Trace ElementsPhase 3, Phase 26001
7
CurcuminPhase 3146458-37-7969516
Synonyms:
1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
1,7-Bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione
1,9-Bis(4-hydroxy-3-methoxyphenyl)-2,7-nonadiene-4,6-dione
C.I. Natural Yellow 3
CI Natural Yellow 3
Cucurmin
Curcuma
Curcumin
Curcumin I
Diferaloylmethane
Diferuloylmethane
Gelbwurz
Golden seal
Haidr
Halad
Haldar
Halud
Hydrastis
 
Indian saffron
Indian turmeric
Kacha haldi
Kurkumin [czech]
Merita earth
Natural yellow 3
Orange root
Safran D'inde
Souchet
Terra merita
Tumeric yellow
Turmeric
Turmeric (>98% curcurmin)
Turmeric oleoresin (79%-85% curcumin)
Turmeric yellow
Yellow ginger
Yellow puccoon
Yellow root
Yo-kin
Zlut prirodni 3 [Czech]
8UbiquinonePhase 3, Phase 2145
9Anti-Inflammatory Agents, Non-SteroidalPhase 34443
10AnalgesicsPhase 311733
11Analgesics, Non-NarcoticPhase 36501
12Anti-Inflammatory AgentsPhase 310729
13MicronutrientsPhase 3, Phase 26001
14AnestheticsPhase 39596
15Pharmaceutical SolutionsPhase 3, Phase 28192
16Anti-Infective Agents, LocalPhase 31880
17Central Nervous System DepressantsPhase 313403
18
Cyclosporineapproved, investigational, vet_approvedPhase 292279217-60-0, 59865-13-35284373, 6435893
Synonyms:
1c5f
1cyn
30024_FLUKA
30024_SIGMA
59865-13-3
79217-60-0
AC1L1EQW
AC1NQXJE
AC1NR4C4
AC1NUQK3
AC1NUZNC
AC1O5KOG
AC1Q2UDG
Ambap59865-13-3
Ambotz59865-13-3
Antibiotic S 7481F1
BMT-ABA-SAR-MLE-VAL-MLE-ALA-ALA-MLE-MLE-MVA
BMT-ABA-SAR-MLE-VAL-MLE-ALA-DAL-MLE-MLE-MVA
BPBio1_000496
BRD-A64290322-001-01-6
BRD-A69815203-001-04-3
BRD-K13533483-001-03-0
BSPBio_000450
BSPBio_001596
BSPBio_003186
C 3662
C05086
C1832_SIGMA
C3662_SIGMA
C62H111N11O12
CB-01-09 MMX
CHEBI:106343
CHEBI:328305
CHEBI:4031
CHEMBL160
CHEMBL386389
CHEMBL532318
CID2909
CID5280754
CID5284373
CID5458585
CID5497195
CID6435893
CSA
CYCLOSPORIN A (SEE ALSO TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A))
CYCLOSPORIN A, USP
Ciclosporin
Ciclosporin (JP15)
Ciclosporina
Ciclosporine
Ciclosporinum
Cipol N
Cipol-N
Consupren
Consupren S
CsA
CsA & IFN.alpha.
CyA
Cyclokat
Cyclosporin
Cyclosporin A
Cyclosporin A & IFN.alpha.
Cyclosporin A Implant
Cyclosporin A, Tolypocladium inflatum
Cyclosporine (USP)
Cyclosporine A
Cyclosporine [USAN]
D00184
DE-076
DivK1c_000871
EU-0100242
Equoral
GNF-Pf-2808
Gengraf
Gengraf (TN)
HMS1569G12
HMS1791P18
HMS1921L20
HMS1989P18
HMS2089A09
HMS2092F06
HMS502L13
Helv Chim Acta 60: 1568 (1977)
 
I06-0379
I06-0966
IDI1_000871
KBio1_000871
KBio2_000780
KBio2_003348
KBio2_005916
KBio3_002686
KBioGR_001898
KBioSS_000780
LMPK14000003
LS-257
LS-58836
Lopac0_000242
MLS000028376
MLS001333756
MLS002153454
MLS002207033
Mitogard
Modusik-A
MolPort-000-760-988
MolPort-005-934-008
MolPort-006-705-994
NCGC00093704-01
NCGC00093704-02
NCGC00093704-03
NCGC00093704-04
NCGC00093704-05
NCGC00093704-06
NCGC00093704-07
NCGC00093704-08
NCGC00164258-01
NCGC00164258-02
NINDS_000871
NSC290193
Neoplanta
Neoral
Neoral (TN)
NeuroSTAT
Nova-22007
OL 27-400
OL-27400
OLO-400
Papilock
Prestwick2_000435
Prestwick3_000435
Prestwick_731
Pulminiq
Ramihyphin A
Restasis
Restasis (TN)
S-Neoral
S1514_Selleck
SDZ-OXL 400
SMR000058578
SPBio_001467
SPECTRUM1502202
ST-603
Sandimmun
Sandimmun Neoral
Sandimmune
Sandimmune (TN)
Sandimmune, Gengraf, Restasis, Atopica, Sangcya, Cyclosporine
Sang-2000
Sang-35
SangCyA
Sangcya
Sigmasporin
Sigmasporin Microoral
Spectrum2_001484
Spectrum3_001593
Spectrum4_001279
Spectrum5_001628
Spectrum_000300
TRANSGENIC MODEL EVALUATION (CYCLOSPORIN A)
Vekacia
Zyclorin
cyclophorine
cyclosporin A
cyclosporine
from Tolypocladium inflatum (Trichoderma polysporin)
nchembio.184-comp6
nchembio.301-comp5
nchembio.342-comp1
19
Miconazoleapproved, investigational, vet_approvedPhase 2370622916-47-84189
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
AKOS001574474
Aflorix(nitrate)
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
CPD-4501
Conofite(nitrate)
D00416
DB01110
Dactarin
Daktarin IV
Daktarin iv
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
LS-78378
Lotrimin AF(nitrate)
MCZ
MJR 1762
MLS002222203
Micantin (nitrate)
Miconasil Nitrate
 
Miconazol
Miconazol [INN-Spanish]
Miconazole
Miconazole (JP15/USP/INN)
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole [USAN:BAN:INN:JAN]
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (TN)
Monistat iv (tn)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
NSC 170986
NSC169434
NSC170986
Novo-Miconazole Vaginal Ovules
Oprea1_091955
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
Prestwick_335
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
STK834405
STOCK1S-93556
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
Spectrum_000965
UNII-7NNO0D7S5M
Vusion
Zimycan
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
miconazole
20
Cysteamineapproved, investigationalPhase 22760-23-16058
Synonyms:
(2-Mercaptoethyl)amine
(Mercaptoethyl)ammonium toluene-p-sulphonate
.beta.-Mercaptoethylamine
1-Amino-2-mercaptoethylamine
139720-70-0
156-57-0 (hydrochloride)
16904-32-8 (di-hydrochloride)
2-AMINO-ETHANETHIOL
2-AMINO-ethanethiol
2-Amino-1-ethanethiol
2-Aminoethanethiol
2-Aminoethyl mercaptan
2-Mercaptoethanamine
2-Mercaptoethylamine
2-Mercaptoethylamine, polymer-bound
27761-19-9 (tartrate (1:1))
2DFDA1F8-7010-4225-8280-AB1C4C43F546
30070_FLUKA
30070_SIGMA
3037-04-5
3037-04-5 (tosylate)
42954-15-4 (hydrobromide)
60-23-1
60-23-1 (Parent)
641022_ALDRICH
93965-19-6 (maleate (1:1))
A0648
AC1L1LPL
AC1Q54NL
AKOS003793343
Aminoethyl mercaptan
Becaptan
C-9500
C01678
C2H7NS
CASH
CCRIS 3083
CHEBI:17141
CHEMBL602
CID6058
CYSTEAMINE
Cisteamina
Cisteamina [Italian]
Cystavision
Cysteamide
Cysteamin
Cysteamine
Cysteamine (USAN)
Cysteamine [USAN:BAN]
Cysteamine bitartate
Cysteamine hydrochloride
Cysteaminium
Cysteinamine
D03634
DB00847
Decarboxycysteine
DivK1c_006750
 
EINECS 200-463-0
EINECS 221-235-7
Ethanethiolamine
HSDB 7353
KBio1_001694
KBio2_002235
KBio2_004803
KBio2_007371
KBioSS_002235
L 1573
L-1573
LS-65761
Lambraten
Lambratene
Lopac-M-6500
M9768_ALDRICH
M9768_SIGMA
MEA
MEA (mercaptan)
Mecramine
Mercamin
Mercamine
Mercaptamin
Mercaptamina
Mercaptamina [INN-Spanish]
Mercaptamine
Mercaptamine (INN)
Mercaptaminum
Mercaptaminum [INN-Latin]
Mercaptoethylamine
Merkamin
MolPort-001-662-635
NCGC00015691-01
NCGC00015691-04
NCGC00162236-01
NCI60_002000
NSC 647528
NSC647528
Riacon
STK315355
SpecPlus_000654
Spectrum_001755
Thioethanolamine
UNII-5UX2SD1KE2
WR 347
b-Aminoethanethiol
b-Aminoethylthiol
b-Mercaptoethylamine
beta-Aminoethanethiol
beta-Aminoethylthiol
beta-MEA
beta-Mercaptoethylamine
bmse000388
cysteamine bitartrate
nchembio.315-comp1
nchembio.316-comp1
β-MEA
β-aminoethylthiol
21Immunosuppressive AgentsPhase 213086
22Anti-Infective AgentsPhase 222062
23Antifungal AgentsPhase 23696
24Calcineurin InhibitorsPhase 21622
25Dermatologic AgentsPhase 25806
26Ophthalmic SolutionsPhase 21140
27Neuroprotective AgentsPhase 11716
28
Triamcinoloneapproved, vet_approved510124-94-731307
Synonyms:
(8S,9R,10S,11S,13S,14S,16R,17S)-9-fluoro-11,16,17-trihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
11-beta,16-alpha,17-alpha,21-Tetrahydroxy-9-alpha-fluoro-1,4-pregnadiene-3,20-dione
11.Beta.,16.alpha.,17.alpha., 21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11.beta.,16.alpha.,17.alpha.,21-Tetrahydroxy-9.alpha.-fluoro-1,4-pregnadiene-3,20-dione
11β,16α,17α,21-tetrahydroxy-9α-fluoro-1,4-pregnadiene-3,20-dione
124-94-7
4-08-00-03629 (Beilstein Handbook Reference)
83474-03-7
9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9-alpha-Fluoro-16-alpha-hydroxyprednisolone
9-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.Alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahy
9.Alpha.-Fluoro-11.beta.,16.alpha.,17.alpha., 21-tetrahydroxypregna-1,4-diene-3,20-d
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-11.beta.,16.alpha.,17.alpha.,21-tetrahydroxypregna-1,4-diene-3,20-dione
9.alpha.-Fluoro-16.alpha.-hydroxyprednisolone
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxy-1,4-pregnadiene-3,20-dione
9alpha-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9alpha-Fluoro-16alpha-hydroxyprednisolone
9α-fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione
9α-fluoro-16α-hydroxyprednisolone
AC-2072
AC1L1LDH
AC1Q5HJC
Adcortyl
Aristocort
Aristocort A
Aristocort Tablets
Aristogel
Aristospan
Azmacort
BPBio1_000154
BRD-K77554836-001-03-3
BRN 2341955
BSPBio_000140
Bio-0662
C21H27FO6
CHEMBL1451
CID31307
CL 19823
Celeste
Cinolone
Cinolone-T
D00385
D014221
DB00620
Delphicort
EINECS 204-718-7
EU-0101179
Fluoxiprednisolone
Fluoxyprednisolone
Flutex
Fougera
HMS1568G22
HMS2090D12
HSDB 3194
Kenacort
Kenacort (TN)
Kenacort-A
Kenacort-AG
Kenacort-Ag
Kenalog
Kenalog in Orabase
Kenalog-10
Kenalog-40
Kenalog-H
LS-698
Ledercort
Lopac0_001179
 
MLS000028542
MLS001066543
MLS002695935
MolPort-002-528-981
Mycolog
NCGC00021580-03
NCGC00021580-04
NCGC00021580-05
NCGC00021580-06
NCGC00021580-07
NCI60_000750
NSC 13397
NSC13397
Nasacort
Nasacort Aq
Nasacort Hfa
Omcilon
Omicilon
Oracort
Oralone
Orion
Polcortolon
Pregna-1,4-diene-3,20-dio
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11beta,16alpha)
Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,16alpha,17,21-tetrahydroxy- (8CI)
Prestwick0_000120
Prestwick1_000120
Prestwick2_000120
Prestwick3_000120
Prestwick_438
Rodinolone
S1933_Selleck
SK-Triamcinolone
SMP1_000300
SMR000058333
SPBio_002079
Sk-Triamcinolone
T6376_SIGMA
TRIAMCINOLONE (SEE ALSO TRIAMCINOLONE ACETONIDE (76-25-5) AND TRIAMCINOLONE DIACETATE (67-78-7))
Tiamcinolonum
Tiamcinolonum [INN-Latin]
Tri-Nasal
Triacet
Triacort
Triam-Tablinen
Triamcet
Triamcinalone
Triamcinlon
Triamcinolon
Triamcinolona
Triamcinolona [INN-Spanish]
Triamcinolone (JP15/USP/INN)
Triamcinolone [USAN:INN:BAN:JAN]
Triamcinolone acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Triamcinolonum
Triamcinolonum [INN]
Triatex
Tricortale
Triderm
Trilone
Tristoject
Trymex
UNII-1ZK20VI6TY
Vetalog
Volon
Volon A
WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ GQ
ZINC03882036
droxypregna-1,4-diene-3,20-dione
ione
nchembio.2007.53-comp7
triamcinolone
29
Vitamin Eapproved, nutraceutical, vet_approved41459-02-914985
Synonyms:
(+)-a-Tocopherol
(+)-alpha-Tocopherol
(+)-α-tocopherol
(2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL
(2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
(2R,4'R,8'R)-a-Tocopherol
(2R,4'R,8'R)-alpha-Tocopherol
(2R,4'R,8'R)-α-tocopherol
(R,R,R)-a-Tocopherol
(R,R,R)-alpha-Tocopherol
(R,R,R)-α-tocopherol
5,7,8-Trimethyltocol
5,7,8-trimethyltocol
Amino-Opti-E
Aquasol E
D-alpha-Tocopherol
Daltose
Denamone
E-200 I.U. Softgels
 
E-Complex-600
E-Ferol
E-Vitamin succinate
Eprolin
Gordo-Vite E
Phytogermin
Phytogermine
RRR-alpha-tocopherol
RRR-alpha-tocopheryl
Tocopherol
Vitamin E
Vitamin Ea
Vitamin Plus E Softgells
Vitec
a-D-Tocopherol
a-Tocopherol
alpha-Tocopherol
alpha-delta-Tocopherol
alpha-tocopherol
d-α-tocopherol
delta-alpha-Tocopherol
30Triamcinolone hexacetonide510
31Triamcinolone diacetate510
32triamcinolone acetonide510
33Tocotrienol, alpha5
34Tocopherols414
35Tocotrienols410
36TocotrienolNutraceutical410
37TocopherolNutraceutical414

Interventional clinical trials:

(show all 25)
idNameStatusNCT IDPhase
1Study to Assess the Efficacy and Safety of Raxone in LHON PatientsRecruitingNCT02774005Phase 4
2A Randomized, Double-blind, Placebo-controlled Trial of Curcumin in Leber's Hereditary Optic Neuropathy (LHON)CompletedNCT00528151Phase 3
3Safety and Efficacy Study of Gene Therapy for The Treatment of Leber's Hereditary Optic NeuropathyRecruitingNCT03153293Phase 2, Phase 3
4Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 MutationRecruitingNCT02652767Phase 3
5Efficacy Study of GS010 for Treatment of Vision Loss From 7 Months to 1 Year From Onset in LHON Due to the ND4 MutationActive, not recruitingNCT02652780Phase 3
6Study With Idebenone in Patients With Chronic Vision Loss Due to Leber's Hereditary Optic Neuropathy (LHON)WithdrawnNCT01495715Phase 3
7Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic NeuropathyUnknown statusNCT02176733Phase 2
8Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic NeuropathyCompletedNCT00747487Phase 2
9Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial DiseaseCompletedNCT02023866Phase 2
10The KHENERGY StudyRecruitingNCT02909400Phase 2
11Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) PatientsActive, not recruitingNCT02064569Phase 1, Phase 2
12A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide (MTP-131) Topical Ophthalmic Solution for the Treatment of Leber's Hereditary Optic NeuropathyActive, not recruitingNCT02693119Phase 2
13Near-infrared Light-emitting Diode (NIR-LED) Therapy for Leber's Hereditary Optic Neuropathy (LHON)TerminatedNCT01389817Phase 1, Phase 2
14A Dose-escalating Clinical Trial With KH176CompletedNCT02544217Phase 1
15Safety Study of a Single IVT Injection of QPI-1007 in Chronic Optic Nerve Atrophy and Recent Onset NAION PatientsCompletedNCT01064505Phase 1
16Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic NeuropathyRecruitingNCT02161380Phase 1
17Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)CompletedNCT01267422
18Leber Hereditary Optic Neuropathy (LHON) Historical Case Record SurveyCompletedNCT01892943
19RHODOS Follow-up Single-visit StudyCompletedNCT01421381
20Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)RecruitingNCT02796274
21Post Authorisation Safety Study With Raxone in LHON PatientsRecruitingNCT02771379
22Stem Cell Ophthalmology Treatment Study IIRecruitingNCT03011541
23Biomechanics of Optic NeuropathyRecruitingNCT02982499
24Inherited Retinal Degenerative Disease RegistryRecruitingNCT02435940
25Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]No longer availableNCT02300753

Search NIH Clinical Center for Leber Optic Atrophy


Cochrane evidence based reviews: optic atrophy, hereditary, leber

Genetic Tests for Leber Optic Atrophy

About this section

Genetic tests related to Leber Optic Atrophy:

id Genetic test Affiliating Genes
1 Leber's Optic Atrophy27
2 Leber Optic Atrophy, Susceptibility to27
3 Leber Hereditary Optic Neuropathy24 MT-ND6

Anatomical Context for Leber Optic Atrophy

About this section

MalaCards organs/tissues related to Leber Optic Atrophy:

36
Eye

Publications for Leber Optic Atrophy

About this section

Articles related to Leber Optic Atrophy:

idTitleAuthorsYear
1
Preliminary exclusion of an X-linked gene in Leber optic atrophy by linkage analysis. (2731932)
1989
2
Leber optic atrophy low vision case report. (3364529)
1988
3
Charcot-Marie-Tooth disease with Leber optic atrophy. (563998)
1978

Variations for Leber Optic Atrophy

About this section

UniProtKB/Swiss-Prot genetic disease variations for Leber Optic Atrophy:

70 (show all 18)
id Symbol AA change Variation ID SNP ID
1MT-ATP6p.Ile192ThrVAR_000795rs199476134
2MT-CO3p.Gly78SerVAR_002167rs267606611
3MT-CO3p.Ala200ThrVAR_002168rs200613617
4MT-CYBp.Asp171AsnVAR_002197rs41518645
5MT-CYBp.Val356MetVAR_002199rs200336777
6MT-ND1p.Ala52ThrVAR_004751rs199476118
7MT-ND2p.Asn150AspVAR_004755rs28357980
8MT-ND2p.Gly259SerVAR_004756rs199476115
9MT-ND4Lp.Val65AlaVAR_008397rs193302933
10MT-ND4p.Arg340HisVAR_004760rs199476112
11MT-ND5p.Ala458ThrVAR_004761rs28359178
12MT-ND5p.Gly465GluVAR_004762rs387906425
13MT-ND5p.Ala171ValVAR_035426rs267606899
14MT-ND6p.Met64ValVAR_004763rs199476104
15MT-ND6p.Gly36SerVAR_008395rs397515506
16MT-ND6p.Tyr59CysVAR_008396rs869025186
17MT-ND6p.Met64IleVAR_008512rs199476108
18MT-ND6p.Leu60SerVAR_014396rs199476106

Clinvar genetic disease variations for Leber Optic Atrophy:

5 (show all 40)
id Gene Variation Type Significance SNP ID Assembly Location
1MT-ND5m.12338T> CSNVPathogenicrs201863060GRCh37Chr MT, 12338: 12338
2MT-ND3m.10237T> CSNVPathogenicrs193302927GRCh37Chr MT, 10237: 10237
3MT-ND4m.11253T> CSNVPathogenicrs200145866GRCh37Chr MT, 11253: 11253
4MT-ND5m.12811T> CSNVPathogenicrs199974018GRCh37Chr MT, 12811: 12811
5MT-ND5m.13637A> GSNVPathogenicrs200855215GRCh37Chr MT, 13637: 13637
6MT-ND6m.14325T> CSNVPathogenicrs397515505GRCh37Chr MT, 14325: 14325
7MT-ND6m.14482C> GSNVPathogenicrs199476108GRCh37Chr MT, 14482: 14482
8MT-ND6m.14498T> CSNVPathogenicrs869025186GRCh38Chr MT, 14498: 14498
9MT-ND6m.14568C> TSNVPathogenicrs397515506GRCh37Chr MT, 14568: 14568
10MT-ND6m.14279G> ASNVPathogenicrs869025187GRCh38Chr MT, 14279: 14279
11MT-CYBm.14831G> ASNVPathogenicrs199795644GRCh37Chr MT, 14831: 14831
12MT-ND1m.3635G> ASNVPathogenicrs397515507GRCh37Chr MT, 3635: 3635
13MT-ND1m.3700G> ASNVPathogenicrs397515508GRCh37Chr MT, 3700: 3700
14MT-ND1m.4025C> TSNVPathogenicrs397515509GRCh37Chr MT, 4025: 4025
15MT-ND1m.3376G> ASNVPathogenicrs397515612GRCh37Chr MT, 3376: 3376
16MT-ATP6m.9101T> CSNVPathogenicrs199476134GRCh37Chr MT, 9101: 9101
17MT-CO3m.9438G> ASNVPathogenicrs267606611GRCh37Chr MT, 9438: 9438
18MT-CO3m.9804G> ASNVPathogenicrs200613617GRCh37Chr MT, 9804: 9804
19MT-CO1; MT-TS1m.7444G> ASNVPathogenicrs199474822GRCh37Chr MT, 7444: 7444
20MT-CYBm.15812G> ASNVPathogenicrs200336777GRCh37Chr MT, 15812: 15812
21MT-ND6NC_ 012920.1: m.14484T> CSNVPathogenic/ Likely pathogenicrs199476104GRCh37Chr MT, 14484: 14484
22MT-ND6m.14459G> ASNVPathogenicrs199476105GRCh37Chr MT, 14459: 14459
23MT-ND6m.14596A> TSNVPathogenicrs387906424GRCh37Chr MT, 14596: 14596
24MT-ND6m.14495A> GSNVPathogenicrs199476106GRCh37Chr MT, 14495: 14495
25MT-ND6m.14482C> ASNVPathogenicrs199476108GRCh37Chr MT, 14482: 14482
26MT-ND5m.13730G> ASNVPathogenicrs387906425GRCh37Chr MT, 13730: 13730
27MT-ND5m.13045A> CSNVPathogenicrs267606895GRCh37Chr MT, 13045: 13045
28MT-ND5m.12848C> TSNVPathogenicrs267606899GRCh38Chr MT, 12848: 12848
29MT-ND4Lm.10663T> CSNVPathogenicrs193302933GRCh37Chr MT, 10663: 10663
30MT-ND4NC_ 012920.1: m.11778G> ASNVPathogenicrs199476112GRCh37Chr MT, 11778: 11778
31MT-ND4m.11696G> ASNVPathogenicrs200873900GRCh37Chr MT, 11696: 11696
32MT-ND2m.5244G> ASNVPathogenicrs199476115GRCh37Chr MT, 5244: 5244
33MT-ND2m.4640C> ASNVPathogenicrs387906426GRCh37Chr MT, 4640: 4640
34MT-ND1NC_ 012920.1: m.3460G> ASNVPathogenicrs199476118GRCh37Chr MT, 3460: 3460
35MT-ND1m.4160T> CSNVPathogenicrs199476119GRCh37Chr MT, 4160: 4160
36MT-ND1m.3394T> CSNVPathogenicrs41460449GRCh37Chr MT, 3394: 3394
37MT-ND1m.4136A> GSNVPathogenicrs199476121GRCh37Chr MT, 4136: 4136
38MT-ND1m.4171C> ASNVPathogenicrs28616230GRCh37Chr MT, 4171: 4171
39MT-ND1m.3697G> ASNVPathogenicrs199476122GRCh37Chr MT, 3697: 3697
40MT-ND1m.3733G> ASNVPathogenicrs199476125GRCh37Chr MT, 3733: 3733

Expression for genes affiliated with Leber Optic Atrophy

About this section
Search GEO for disease gene expression data for Leber Optic Atrophy.

Pathways for genes affiliated with Leber Optic Atrophy

About this section

GO Terms for genes affiliated with Leber Optic Atrophy

About this section

Cellular components related to Leber Optic Atrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1mitochondrial membraneGO:003196610.4MT-ND1, MT-ND3, MT-ND4, MT-ND4L, MT-ND6, NDUFA1
2respiratory chain complex IVGO:004527710.2MT-CO1, MT-CO3
3mitochondrial respiratory chain complex IGO:000574710.1MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5
4mitochondrial inner membraneGO:00057439.2MT-ATP6, MT-CO1, MT-CO3, MT-CYB, MT-ND1, MT-ND2
5mitochondrionGO:00057399.1MT-CO1, MT-CO3, MT-CYB, MT-ND1, MT-ND3, MT-ND4
6integral component of membraneGO:00160219.1EPHX1, MT-ATP6, MT-CO1, MT-CO3, MT-CYB, MT-ND1
7respiratory chainGO:00704699.0MT-CO1, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4
8membraneGO:00160208.6EPHX1, MT-ATP6, MT-CO1, MT-CO3, MT-CYB, MT-ND1

Biological processes related to Leber Optic Atrophy according to GeneCards Suite gene sharing:

(show all 13)
idNameGO IDScoreTop Affiliating Genes
1mitochondrial electron transport, cytochrome c to oxygenGO:000612310.9MT-CO1, MT-CO3
2cellular respirationGO:004533310.9MT-ND1, NDUFS4
3ATP synthesis coupled electron transportGO:004277310.8MT-ND4, MT-ND4L, MT-ND5
4mitochondrion morphogenesisGO:007058410.8OPA1, OPA3
5respiratory electron transport chainGO:002290410.8MT-CO3, MT-CYB
6hydrogen ion transmembrane transportGO:190260010.8MT-CO1, MT-CO3, MT-CYB
7response to hyperoxiaGO:005509310.8MT-ATP6, MT-CYB
8response to copper ionGO:004668810.7MT-CO1, MT-CYB
9agingGO:000756810.6MT-ATP6, MT-CO1, MT-ND4, OPA1
10mitochondrial respiratory chain complex I assemblyGO:003298110.0MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND5, MT-ND6
11response to organic cyclic compoundGO:001407010.0EPHX1, MT-CYB, MT-ND1
12mitochondrial electron transport, NADH to ubiquinoneGO:00061209.9MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5
13oxidation-reduction processGO:00551149.5MT-CO1, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4

Molecular functions related to Leber Optic Atrophy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1oxidoreductase activity, acting on NAD(P)HGO:001665110.1MT-ND4L, NDUFS4
2NADH dehydrogenase (ubiquinone) activityGO:00081379.9MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5
3oxidoreductase activityGO:00164919.6MT-CO1, MT-CYB, MT-ND1, MT-ND2, MT-ND3, MT-ND4

Sources for Leber Optic Atrophy

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet